Title : Hyperoside inhibits pancreatic lipase activity in vitro and reduces fat accumulation in vivo - Zhang_2023_Food.Funct_14_4763 |
Author(s) : Zhang X , Li D , Wang K , Xie J , Liu Y , Wang T , Liu S , Huang Q , Guo Q , Wang H |
Ref : Food Funct , 14 :4763 , 2023 |
Abstract :
Hyperoside, the main component of many anti-obesity plants, might exhibit a lipase inhibition effect to reduce fat accumulation. The anti-obesity effect of hyperoside was investigated by studying its inhibitory effect and mechanism on pancreatic lipase in vitro and evaluating its ability to reduce lipid accumulation in vivo. Hyperoside is a mixed-type inhibitor of lipase with an IC(50) of 0.67 +/- 0.02 mmol L(-)in vitro. Hyperoside changed the secondary conformation of lipase, increased the alpha-helix content, and changed the microenvironment of lipase through static quenching. The interaction between hyperoside and lipase results from a strong binding spontaneous exothermic reaction, mainly through hydrogen bonding, van der Waals force and electrostatic force. Hyperoside protected hepatic lipid accumulation and adipose tissue hypertrophy and reduced the expression of inflammatory factors in high-fat diet-induced rats. Moreover, hyperoside had a good inhibitory effect on lipase activity in serum and increased fecal fat excretion, thereby reducing lipid absorption in vivo. This study provides theoretical support for the research and development of hyperoside in fat-reducing functional foods. |
PubMedSearch : Zhang_2023_Food.Funct_14_4763 |
PubMedID: 37128768 |
Zhang X, Li D, Wang K, Xie J, Liu Y, Wang T, Liu S, Huang Q, Guo Q, Wang H (2023)
Hyperoside inhibits pancreatic lipase activity in vitro and reduces fat accumulation in vivo
Food Funct
14 :4763
Zhang X, Li D, Wang K, Xie J, Liu Y, Wang T, Liu S, Huang Q, Guo Q, Wang H (2023)
Food Funct
14 :4763